Spanish Startup Riders

Share this post

🌊 Gene Editing

www.startupriders.com

🌊 Gene Editing

Gene Editing: why now, what the market looks like and how to surf it.

Startup Riders
Oct 7, 2022
8
Share this post

🌊 Gene Editing

www.startupriders.com

Hello! I’mĀ Ivan Landabaso, partner atĀ JME.vc. Join >4.5K entrepreneurs surfing startup trends. Once or twice per month. From Spain to the šŸŒ


Summary

Gm startup riders! This week’s good stuff for your startup brain includes:

  1. 🧬 Gene Editing: why now and what the market looks like.

  2. šŸ¬ Startup Candy: Glovo & Cabify multiplier effect, robotics and prioritisation.

  3. šŸ’µĀ Deals & Jobs: 25 startup deals in Spain (>€110M).


🧬 Gene Editing

This week my good friend Philippe Koch - cellular and molecular biologist currently at ZS - takes us down the Gene Editing rabbit hole. Lets go:

Improve your Gene Editing Success with CRISPR-SNIPER Technology
Source

😟 Problem

For as long as we’ve been getting sick, we’ve been trying to cure the different conditions and diseases that impact us. Unfortunately, many treatments fall short of this goal and instead focus on managing the symptoms rather than the underlying cause.

🤩 Solution

Cell & gene therapies aim to do just that; science has found ways to correct the underlying errors in our genetic building blocks or even program our body’s ability to fight diseases … There are treatments out there that provide ā€œcuresā€ (any big statement like that comes with disclaimers, more on that below…)

ā³ How we got here

The concept of using cell and gene therapies isn’t new – in fact, we’ve already seen a cell and gene therapy revolution of sorts in the 90s when, for the first time ever, we successfully alleviated a person’s genetic defect (think error in your body’s operating system) by introducing a correct and functioning version of that gene into their body.

Whilst the effects were not permanent, this was an exciting milestone that saw new technologies quickly developed.

Inspired by viruses (hate to say it but think covid) we managed to harness their unique ability of hacking our operating systems to make us produce more copies of themselves. In doing so, we created ā€œgoodā€ viruses that could hack and insert the right genes into our operating system.

Unfortunately, this success was short lived as a patient died due to complications which put a pause on things as we realized we needed to go back to the drawing board…

Over the years research went into refining other viral delivery methods and therapies such as CAR-Ts; this last one being especially cool as this cell therapy essentially programs T-Lymphocytes - think the Robocops of your blood - to become better at detecting and destroying cancer. Whilst this was exciting, progress was relatively slow until…

CRISPR came along:

The Ultimate Guide To CRISPR: Mechanism, Applications, Methods & More
Source

CRISPR was first discovered as scientists studied how bacteria protected themselves against viruses, from there it was then adapted to be applicable in humans picking up the 2020 Nobel prize in chemistry along the way.

CRISPR essentially gives researchers the ability to FIND and REPLACE faulty genetic code with the correct sequence… that’s like being able to pick out that spelling mistake on page 96 of your body’s operating manual.

Pretty neat, no? Not so fast! This technology is still somewhat in its infancy and a lot of work is going into making sure that no ā€˜off-target’ replacements are made… think about it - how many times have you used FIND/REPLACE in a word or ppt presentation as a lazy way to bring in some last-minute revision only to find whole sentences now jumbled throughout the document? Now think about the consequences if you did that to your body’s operating manual…

We are at a point where CRISPR technology can be used not only to treat conditions but even to engineer super humans. A couple of years back, a scientist announced he had genetically engineered human embryos to be HIV resistant - whilst on the face of it that might seem like a worthwhile cause it does open a host of ethical dilemmas which I won’t get to here … suffice it to say the (now disgraced) scientist in question also had plans of launching a ā€œgenetic medical tourismā€ company.

15 Breakdancing Innovations

Ā šŸ—ŗļø Market Map

For those that want to get geeky with it, Cell and Gene therapies can be bucketed into different categories. True to their name, you can have cell-based therapies (such as the CAR-Ts treatments mentioned above) that either rely on harvesting your own cells (Auto=self) or come from a donor (Allo=other).

To complicate matters, you can enhance these cell-based treatments with Gene editing tools such as CRISPR (ex-vivo = outside your body) OR you can also go the direct route and receive the Gene Therapy straight into your body (in-vivo = inside your body).Ā 

Check out the below visual as a recap (courtesy of my employer: ZS Associates)Ā 

The field of cell and gene therapy is expected to absolutely boom with a lot of companies that are in clinical trials right now - by 2025 we’d expect to have around 30 gene and an additional 30 cell therapies on the market. Compared to the handful of therapies on the market right now, that’s an insane amount of expected growth!Ā 

Check out the below graphic for some more details:

Source: ZS Associates

Amongst others, some of the main challenges cell and gene therapies are facing are:

1. Patient access - making sure that everyone has equal access to these treatments is tricky due to a number of reasons which include - specific genetic testing is not widespread, these advanced therapies can generally only be obtained at big academic hospitals and the reimbursement is complex (and still being defined)

2. Manufacturing - cell and gene therapies are complex and laborious to make so this is becoming a real bottleneck that manufacturers are having to solve. Fun fact I heard at a recent conference: apparently baristas and bakers make up most of the talent pool that’s filling the current staffing shortage at manufacturing facilities - must be something about being able to follow detailed recipes!

Ā šŸš€ My favorites

  • Novartis Gene Therapies - Zolgensma. Transforms the course of a disease in children that would have almost certainly died by the age of 2.

  • GenSight – Whilst still in clinical trials – GenSight is looking into using a gene therapy to restore vision.

  • Matricelf – Also still very much clinical, but combines 3D printing with cell therapies to repair a person’s heart after they have had a heart attack

  • A special shoutout also to GenMab, who are located right around the corner in Utrecht, who are doing some amazing work to develop specialized antibodies for the treatment of cancer

šŸ‘€ Watch out

Notice how I said ā€œCureā€ earlier? How often have you seen that super click-baity article that claimed that ā€œWe’ve cured cancer!ā€?.... and yet most of us will still be or have loved ones be impacted by cancer.

So where’s this cure then? As always, the answer is, it’s complicated:

  1. The term cancer describes of host of conditions that manifest in the uncontrollable replication of cells - problem is there’s a huge number of different types of cells in our bodies and an even bigger number of things that can cause this so there really isn’t a ā€œone size fits allā€ type of solution (at least for now)

  2. When we say ā€œcureā€ that’s to the best of our knowledge - we simply don’t have the long-term data that would indicate otherwise. Whilst the hope is that a cell or gene therapy’s durability will last a lifetime, this technology is simply too young for us to say that with 100% certainty. Not only is that a stark reality check for any patients that have been ā€œcuredā€ but it also opens up some interesting reimbursement questions especially when the one of the reasons for the eye watering prices of these treatments (think up to multimillion $ / treatment) is their ā€œcurativeā€ properties

šŸ‡ Follow the White Rabbit šŸ•³ļø

  • ZS Insights: I work with ZS Associates where I’ve been lucky enough to work with a bunch different Cell and Gene therapy companies at different commercial stages - that gives us a unique perspective in this space.

  • The BBC made an amazing documentary that follows the lives of 2 patients undergoing cell therapies - it’s a sobering reminder that the field of cell and gene therapy, for all its advances, still has a ways to go and that there are a bunch of things we can improve beyond just the science to help patients (link)


šŸ¬ Sartup Candy

1. Glovo & Cabify: ecosystem multipliers.

Twitter avatar for @IvanLandabaso
Ivan Landabaso @IvanLandabaso
El efecto multiplicador de Glovo y Cabify. Via: endeavor
Image
Image
8:59 AM āˆ™ Sep 26, 2022
332Likes64Retweets

2. General purpose robotics: big wave coming.

Twitter avatar for @TechAmazing
Tech Burrito @TechAmazing
A cleaning robot.
1:28 AM āˆ™ Sep 11, 2022
12,784Likes2,560Retweets

3. There power of prioritisation

Twitter avatar for @TrungTPhan
Trung Phan @TrungTPhan
Steve Jobs famously said innovation is "saying no to 1000 things" before you say yes. For more than a decade, Apple has used Pablo Picasso's Bull to drive home the lesson. Here's a breakdown 🧵
Image
2:25 PM āˆ™ Jul 8, 2022
20,539Likes4,254Retweets

šŸ’µ Startup Deals & Jobs

Deals

You love startups and want to enjoy a Spanish lifestyle? Come join the Spanish startup ecosystem. Here’s a list of recently funded startups:

  • Exoticca (traveltech) raised 20M

  • Cledara (saas) raised 20M

  • Toquio (fintech) raised 20M

  • Good News (coffee) raised 11M

  • Penpot (design) raised 8M

  • Metricool (analytics) raised 5M

  • PropHero (proptech) raised 5M

  • PandaGo (mobility) raised 4.7M - JME Ventures portfolio

  • Tuio (insuretech) raised 3M

  • Reveni (fintech) raised 3M - JME Ventures portfolio

  • PSquared (proptech) raised 1.6M

  • Innomylabs (footech) raised 1.3M

  • Cuyna (dark kitchens) raised 1.2M

  • Lisa (insuretech) raised 1.2M

  • Union Avatars (gaming) raised 1.2M

  • Tennders (logistics) raised 1.2M

  • Box2Box (logistics) raised 1.1M

  • Indya (sports) raised 1M

  • Vitruve (sports) riased 1M

  • Hotelverse (tourism) raised 1M

  • Lifecole (edtech) raised 750K

  • Ripfoods (foodtech) raised 600K

  • Nivimu (hr saas) raised 500K

  • Mixo (foodtech) raised 500K

  • Solfy (energy) raised 400K

  • Clickout raised 100K


What'd you think of today's email?

  • šŸ¦„šŸ¦„šŸ¦„šŸ¦„šŸ¦„ Great stuff, keep it up!

  • šŸ¦„šŸ¦„šŸ¦„ Meh, you can do better

  • šŸ¦„ Bad wipeout

Normal Surfing Not Enough? Time to Get Out the Kite
Share this post

🌊 Gene Editing

www.startupriders.com
Comments
TopNewCommunity

No posts

Ready for more?

Ā© 2023 Startup Riders
Privacy āˆ™ Terms āˆ™ Collection notice
Start WritingGet the app
SubstackĀ is the home for great writing